Objectives
The purpose of this experimental in vivo investigation was to evaluate the influence of modifying the implant surface by adding a monolayer of multi‐phosphonate molecules on the de novo bone formation and osseointegration.
Material and Methods
The study was designed as an animal preclinical trial with intra‐animal control and two healing periods, 2 and 8 weeks, to compare implants with an identical macro‐design but with two different surfaces. Eight female Beagle dogs participated in the study. Control implants had a moderately rough surface combining sandblasting and acid etching; test implants had an additional monophosphonate layer covalently bonded to titanium. Histologic and radiographic (micro‐CT) outcome variables were evaluated.
Results
The first bone‐to‐implant contact (fBIC) was located more coronally for the test implants at the first (0.065 mm (95% CI = −0.82, 0.60)) and second healing milestones (0.17 mm (95% CI = −0.9, 0.55)). Most coronal BIC of the test implants displayed a higher percentage of osseointegration, +6.33% and +13.38% after 2 and 8 weeks, respectively; however, the differences were not statistically significant. The micro‐CT examination did not show any BIC difference.
Conclusions
The monophosphonate layer coating demonstrated clinical, histological, and radiographic results similar to the control surface.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.